about
Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmiasBrain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac deathClinical applicability of molecular biology: the case of the long QT syndrome.Long-QT syndrome: from genetics to managementRationale and objectives for ECG screening in infancyLong QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypesAn LQTS6 MiRP1 mutation suppresses pacemaker current and is associated with sinus bradycardiaLeft cardiac sympathetic denervation in long QT syndrome patients.Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome.QTc dispersion measurement for risk of syncope in patients with aortic stenosis.The clinical significance of QTc dispersion measurement for risk of syncope in patients with aortic stenosis.Congenital myocardial sympathetic dysinnervation (CMSD)--a structural defect of idiopathic long QT syndrome.Consistent linkage of the long-QT syndrome to the Harvey ras-1 locus on chromosome 11Sudden death in the young.QTc: how long is too long?Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome.Inherited long QT syndrome: clinical manifestation, genetic diagnostics, and therapy.Long QT syndrome: a Korean single center study.Hereditary long QT syndrome associated with cardiac conduction system disease.Congenital and drug-induced long-QT syndrome: an update.Current approaches to the clinical assessment of syncope in pediatric population.Improved Clinical Risk Stratification in Patients with Long QT Syndrome? Novel Insights from Multi-Channel ECGsEarly afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome.Provocative testing and drug response in a patient with the long QT syndrome.Epiglottitis and torsade de pointes tachycardiaMolecular genetic aspects of the Romano-Ward long QT syndrome.Syncope and the autonomic nervous system.Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility.Of founder populations, long QT syndrome, and destiny.Counselling pitfalls in Romano-Ward syndromeEvidence of genetic and phenotypic heterogeneity in the Romano-Ward syndrome.Familial ventricular tachycardia: a report of four families.QT interval variables from 24 hour electrocardiography and the two year risk of sudden death.The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart.The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long QT syndromeHERG1 channelopathiesEffect of propranolol on the QT intervals of normal individuals during exercise: a new method for studying interventions.Impact of genetics on the clinical management of channelopathies.Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprololMechanisms of action of antiarrhythmic drugs relative to the origin and perpetuation of cardiac arrhythmias.
P2860
Q24314905-42281810-1131-468D-A3DC-831D46387BB2Q24615319-4D80D59F-EC60-4F16-BB12-EE21CAD5DBB9Q24792627-3FF20263-D21F-4CA9-A7D2-F60D08F12251Q26823298-F960C111-9C7D-487A-96D8-D4098A6E257BQ27009334-5E50246A-77A2-4825-9294-7754DA28FECCQ28116813-E62D5C9A-95F9-4AF3-894F-453E505F5334Q28289868-7DBE9437-CAA2-4A39-8676-33D78422FA6FQ33144622-2CB16715-984E-4953-A73F-F3FD557FC7ACQ33145778-3ACD1DD1-E2E1-46FE-BCA9-9BA529CFA007Q33146356-BEDCD271-4650-4F96-B579-6F5121812F84Q33147767-FCC8DB6D-4E39-4BEF-9098-FBCB3DFC4F37Q33154637-C90D2B43-87E0-40D4-9998-E3727854A73BQ33155081-346863C3-6739-43C9-ADDB-9849FC3F3299Q33155297-D3EEE06F-83B2-4B00-8A06-B3B0ACDF3852Q33157779-5D34AECF-66DF-4D29-B12C-DDECD4BA1CF1Q33160170-AEE64333-FFDA-43C0-A85F-4B049A6A88BAQ33161775-036DEE86-7739-4888-83C2-20552317E152Q33163411-401FF380-5A0B-4C18-88F2-05FF14A79638Q33164010-3F3CF03D-0312-4A2C-8EC8-27D67F6E107DQ33165312-B6182228-3EF8-4A43-8B2D-AF64C2ACC015Q33166635-1CDC1D89-792D-494E-8F76-733A299F232EQ33167382-2A092AF6-F32A-4E1E-80F2-AAD6FBDDF45FQ33173672-584D577A-1072-47FE-AE08-FDCABD75BE18Q33173689-6EBB747E-1C43-41D3-B372-1C98D9EE4228Q33173934-475796EC-DDC4-431C-AFAD-0D46299AAD63Q33174174-4816D0A0-CDDC-4A52-A787-C044FDED88D9Q33174895-E2A55D08-F3DF-42EB-B40F-A6717DABDB3EQ33544548-6EDDFC34-3F29-4082-A651-DA4B8AEF0C9BQ33575898-26F5FFC7-79FD-493B-ABEE-5A6AAE10E03CQ33595933-5916E4D5-77F9-4D26-8531-C0D6F9332A6EQ33596001-E54F2052-9C7D-47A2-BA20-A913C0E6EFE8Q33610568-B7B82B9C-709D-4E54-8BA1-0D90A6777E53Q33613134-A9CFEFB0-49CD-4C46-80B3-49C48F9E680AQ33722232-1EB960F0-7800-4EFD-B77F-39BC157F0ADEQ33807136-C5D42924-C448-4F70-939B-D1F5E6206821Q33915930-D09956EE-707A-43F9-BC27-B097C8225CABQ33999858-71BCDE9F-15B5-4216-B9BD-3BED403B4E17Q34036797-861AFCF0-1E0E-4D3A-8E12-27E5220B2802Q34307224-333FC05C-37E3-4653-995E-5D5B8B8E071FQ34308117-AD4A0F8D-BEF9-471E-AACC-8509F3E29305
P2860
description
1985 nî lūn-bûn
@nan
1985 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Idiopathic long QT syndrome: progress and questions.
@ast
Idiopathic long QT syndrome: progress and questions.
@en
type
label
Idiopathic long QT syndrome: progress and questions.
@ast
Idiopathic long QT syndrome: progress and questions.
@en
prefLabel
Idiopathic long QT syndrome: progress and questions.
@ast
Idiopathic long QT syndrome: progress and questions.
@en
P1476
Idiopathic long QT syndrome: progress and questions.
@en
P2093
Schwartz PJ
P304
P356
10.1016/0002-8703(85)90626-X
P407
P577
1985-02-01T00:00:00Z